However, multivariate analysis excluding these nine patients yielded similar results, with the same variables remaining significant.
In the multivariate analysis excluding SCS outcome, the significance of all the three factors during primary treatment disappeared.
To examine this, we conducted a separate multivariate analysis excluding more than one participant from the same household (remaining N = 320).
Furthermore, in a multivariate analysis excluding BTG2, the same variables without lymph node involvement were selected as prognostic indicators (Supplementary Table S3).
We therefore performed a second multivariate analysis excluding physicians' preferences in order to explore whether other factors also played a role (Table 5).
We examined a final multivariate model that included all confounding variables, and then we repeated the final multivariate analysis excluding mothers who exceeded thresholds for depression at the time they completed the cognitive style measure.
The identification of CXCR2 overexpression as a predictive factor for cancer relapse and poor survival was confirmed in multivariate analysis excluding confounding factors such as treatment with neoadjuvant chemotherapy or anti-VEGF neoadjuvant biotherapy.
In multivariate analysis (excluding P1PS whose data were only available for 159 patients), the RPA, Le Scodan's score, and GPA were found to be the best independent predictors of overall survival.
To exclude the possible effects of hypothermia, we further performed multivariate logistic analysis excluding data from 106 patients with low body temperature (≤ 35°C) during ICU stay (Table 5).
Participants with missing data on variables included in the multivariate analysis were excluded.
